Literature DB >> 30961828

The Gut-Brain Axis, Paving the Way to Brain Cancer.

Ruty Mehrian-Shai1, Juergen K V Reichardt2, Curtis C Harris3, Amos Toren4.   

Abstract

The gut-brain axis formed by blood and lymphatic vessels paves the way for microbiota to impact the brain. Bacterial populations in the gut are a good candidate for a nongenetic factor contributing substantively to brain tumor development and to the success of therapy. Specifically, suppression of the immune system and induction of inflammation by microbiota sustain proliferative signaling, limit cell death, and induce angiogenesis as well as invasiveness. In addition, altered microbial metabolites and their levels could stimulate cell proliferation. We propose here a novel gear model connecting these complex interdisciplinary fields. Our model may impact mechanistic studies of brain cancer and better treatment outcomes through precision oncology.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  brain tumors; cytokines; glioblastoma multiforme; immune system; microbiome

Mesh:

Substances:

Year:  2019        PMID: 30961828      PMCID: PMC6734924          DOI: 10.1016/j.trecan.2019.02.008

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  85 in total

1.  Antigen-presenting capability of glial cells under glioma-harboring conditions and the effect of glioma-derived factors on antigen presentation.

Authors:  Y Taniguchi; K Ono; S Yoshida; R Tanaka
Journal:  J Neuroimmunol       Date:  2000-11-01       Impact factor: 3.478

2.  Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease.

Authors:  S Sakaguchi; R Setoguchi; H Yagi; T Nomura
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

3.  IL-4 attenuates the neuroinflammation induced by amyloid-beta in vivo and in vitro.

Authors:  Anthony Lyons; Rebecca J Griffin; Ceire E Costelloe; Rachael M Clarke; Marina A Lynch
Journal:  J Neurochem       Date:  2007-01-23       Impact factor: 5.372

4.  CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas.

Authors:  Abdeljabar El Andaloussi; Maciej S Lesniak
Journal:  J Neurooncol       Date:  2007-01-10       Impact factor: 4.130

5.  The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.

Authors:  S Farzana Hussain; David Yang; Dima Suki; Kenneth Aldape; Elizabeth Grimm; Amy B Heimberger
Journal:  Neuro Oncol       Date:  2006-06-14       Impact factor: 12.300

6.  History of allergies and risk of glioma in adults.

Authors:  Minouk J Schoemaker; Anthony J Swerdlow; Sarah J Hepworth; Patricia A McKinney; Martie van Tongeren; Kenneth R Muir
Journal:  Int J Cancer       Date:  2006-11-01       Impact factor: 7.396

7.  Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors.

Authors:  Abdeljabar El Andaloussi; Yu Han; Maciej S Lesniak
Journal:  J Neurosurg       Date:  2006-09       Impact factor: 5.115

8.  Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation.

Authors:  Chunhai Hao; Ian F Parney; Wilson H Roa; Joan Turner; Kenneth C Petruk; David A Ramsay
Journal:  Acta Neuropathol       Date:  2001-11-22       Impact factor: 17.088

Review 9.  Molecular mechanisms of aging-associated inflammation.

Authors:  Devanand Sarkar; Paul B Fisher
Journal:  Cancer Lett       Date:  2005-06-22       Impact factor: 8.679

10.  Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD.

Authors:  Carol A Colton; Ryan T Mott; Hayley Sharpe; Qing Xu; William E Van Nostrand; Michael P Vitek
Journal:  J Neuroinflammation       Date:  2006-09-27       Impact factor: 8.322

View more
  22 in total

Review 1.  Clinical correlates for immune checkpoint therapy: significance for CNS malignancies.

Authors:  Nivedita M Ratnam; Stephen C Frederico; Javier A Gonzalez; Mark R Gilbert
Journal:  Neurooncol Adv       Date:  2020-11-27

Review 2.  Key promoters of tumor hallmarks.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Int J Clin Oncol       Date:  2021-11-13       Impact factor: 3.402

Review 3.  Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated.

Authors:  Keywan Mortezaee; Jamal Majidpoor; Ebrahim Kharazinejad
Journal:  Med Oncol       Date:  2022-09-07       Impact factor: 3.738

4.  Age at diagnosis and sex interact to modify primary malignant glioma incidence and survival.

Authors:  Judith Schwartzbaum; Randall Harris
Journal:  Neuro Oncol       Date:  2022-02-01       Impact factor: 12.300

5.  Glioma induced alterations in fecal short-chain fatty acids and neurotransmitters.

Authors:  Antonio Dono; Anthony Patrizz; Ryan M McCormack; Nagireddy Putluri; Bhanu P Ganesh; Balveen Kaur; Louise D McCullough; Leomar Y Ballester; Yoshua Esquenazi
Journal:  CNS Oncol       Date:  2020-06-30

Review 6.  Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics.

Authors:  Artemiy S Silantyev; Luca Falzone; Massimo Libra; Olga I Gurina; Karina Sh Kardashova; Taxiarchis K Nikolouzakis; Alexander E Nosyrev; Christopher W Sutton; Panayiotis D. Mitsias; Aristides Tsatsakis
Journal:  Cells       Date:  2019-08-09       Impact factor: 6.600

7.  Exogenous bacterial DnaK increases protein kinases activity in human cancer cell lines.

Authors:  Francesca Benedetti; Sabrina Curreli; Robert C Gallo; Davide Zella
Journal:  J Transl Med       Date:  2021-02-09       Impact factor: 5.531

Review 8.  Gut microbiota influence tumor development and Alter interactions with the human immune system.

Authors:  Yanshan Ge; Xinhui Wang; Yali Guo; Junting Yan; Aliya Abuduwaili; Kasimujiang Aximujiang; Jie Yan; Minghua Wu
Journal:  J Exp Clin Cancer Res       Date:  2021-01-25

9.  Severe consequences of a high-lipid diet include hydrogen sulfide dysfunction and enhanced aggression in glioblastoma.

Authors:  Daniel J Silver; Gustavo A Roversi; Nazmin Bithi; Sabrina Z Wang; Katie M Troike; Chase Ka Neumann; Grace K Ahuja; Ofer Reizes; J Mark Brown; Christopher Hine; Justin D Lathia
Journal:  J Clin Invest       Date:  2021-07-13       Impact factor: 19.456

10.  Problems associated with a highly artificial ketogenic diet: Letter to the Editor Re: van der Louw EJTM, Olieman JF, van den Bemt PMLA, et al. 'Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study'.

Authors:  Rainer Johannes Klement; Reinhart A Sweeney; Elena C Gross; Colin E Champ
Journal:  Ther Adv Med Oncol       Date:  2019-10-14       Impact factor: 8.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.